Lexpos News

/Lexpos News/

Expiry of fourteen SSPs

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of the following products are now available to meet normal demand: Sandrena® 0.5mg gel sachets Sandrena® 1mg gel sachets Lipitor® 10mg chewable tablets Phenoxymethylpenicillin 125mg/5ml oral solution Phenoxymethylpenicillin 125mg/5ml oral solution sugar free Phenoxymethylpenicillin 250mg/5ml oral solution Phenoxymethylpenicillin 250mg/5ml oral solution sugar free [...]

The post Expiry of fourteen SSPs appeared first on PSNC Website.

By |May 12th, 2023|Lexpos News|Comments Off on Expiry of fourteen SSPs

MPs, Peers and media focus on community pharmacy

Community pharmacies have had further backing from MPs, Peers and others following the announcement of the Government and NHS plans to expand their roles this week. As Secretary of State for Health Steve Barclay announced the plans to invest £645m in the sector in Parliament on Tuesday, he praised the clinical expertise in the sector [...]

The post MPs, Peers and media focus on community pharmacy appeared first on PSNC Website.

By |May 11th, 2023|Lexpos News|Comments Off on MPs, Peers and media focus on community pharmacy

Price concession update for April 2023 – Chlorphenamine 2mg/5ml oral solution

Chlorphenamine 2mg/5ml oral solution (150ml) was inadvertently omitted from PSNC’s final price concession update for April published on 28th April 2023. Drug Pack size Price concession Chlorphenamine 2mg/5ml oral solution 150 £3.34 All prescriptions submitted as dispensed in April 2023 will be reimbursed at £3.34 and not as printed in the Drug Tariff for April 2023. [...]

The post Price concession update for April 2023 – Chlorphenamine 2mg/5ml oral solution appeared first on PSNC Website.

By |May 10th, 2023|Lexpos News|Comments Off on Price concession update for April 2023 – Chlorphenamine 2mg/5ml oral solution

National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure. National Patient Safety Alert Reference Number: NatPSA/2023/004/MHRA Date issued: 9th May 2023 Emerade 500 micrograms solution for injection in pre-filled syringe, PL 33616/0015 (SNOMED Code 23420111000001107) Emerade 300 micrograms [...]

The post National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors appeared first on PSNC Website.

By |May 9th, 2023|Lexpos News|Comments Off on National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors

End of antiviral medicine prescribing for 2022/23 influenza season

In light of surveillance data indicating that circulation of influenza in the community has returned to baseline levels, the Department of Health and Social Care has published an alert to inform prescribers working in primary care and pharmacy teams that antiviral medicines should no longer be prescribed.  Community pharmacists should no longer supply antiviral medicines [...]

The post End of antiviral medicine prescribing for 2022/23 influenza season appeared first on PSNC Website.

By |May 9th, 2023|Lexpos News|Comments Off on End of antiviral medicine prescribing for 2022/23 influenza season